Richard S Geary
CIK 1442730 · EVP, Chief Development Officer · last filed 2025-11-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.16M
Companies
2
Total Filings
112
Lifetime Open-Market Net
-$31.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP, Chief Development Officer | 77,957 | $53.41 | $4.16M | -$23.74M | 60 | 2025-11-07 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | SVP, Development | 4,820 | — | — | -$7.99M | 38 | 2015-07-02 |
Recent Filings · Page 8 of 12
112 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-04 | IONS | Mixed | +640 | $13.3K | EDGAR |
| 2016-07-01 | IONS | Other (J) | +163 | $3.4K | EDGAR |
| 2016-01-19 | IONS | Mixed | +3,265 | -$89.6K | EDGAR |
| 2016-01-04 | IONS | Mixed | +269 | $12.8K | EDGAR |
| 2015-07-02 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Other (J) | +265 | $12.9K | EDGAR |
| 2015-03-20 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$482.5K | EDGAR |
| 2015-03-09 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | −3,015 | -$1.15M | EDGAR |
| 2015-01-20 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +2,506 | -$104.9K | EDGAR |
| 2015-01-13 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Sell (S) | −597 | -$43.6K | EDGAR |
| 2015-01-05 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +273 | $8.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.